Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Reader in Health Service Operations, University of Bradford
Dr Liz Breen is the current Director of the Digital Health Enterprise Zone, an innovation facility based at the University of Bradford. She is also a Reader in Health Service Operations having held previous position of Senior Lecturer in Operations Management at the University of Bradford Faculty of Management and Law for 13 years.
Prior to this she worked in the University of Manchester Business School as a Lecturer in Operations Management and within the NHS.
Liz’s research focuses on improvement in healthcare service supply chains with a specific interest in the pharmaceutical supply chain. Her work aims to better understand healthcare systems so that they can be improved to ensure greater patient safety and optimal care. Ongoing projects in this area include an evaluation of stressors affecting 999 call handlers with the Yorkshire Ambulance Service (YAS) and the impact of Covid-19 pandemic on community pharmacies. Liz is deputy theme lead for the Safe Use of Medicines in the Yorkshire and Humber Patient Safety Translational Research Centre and co-lead on the Process Evaluation stream of the NIHR-funded ISCOMAT study, focusing on patient safety and medicines transitions. She is also co-investigator on an NIHR-funded study examining access to medicines at end of life, the ActMed study.
Projects focusing directly on the pharmaceutical supply chain explore areas such as medicines shortages, medicines waste management, supply chain risk and medicines deliveries during the pandemic.
She is keen to develop the profile and relevance of Operations and Supply Chain Management in healthcare service supply chains within her research, teaching and business engagement.
Dec 04, 2021 02:00 am UTC| Health
What impact the new omicron variant will have is still unknown. But with early data suggesting it could be the most transmissible form of the virus yet and that it could be less susceptible to existing antibodies it...
If you thought that vaccine hesitancy was the biggest challenge of the pandemic, think again. A new challenge is approaching: supply chain hesitancy. The potential for interruption along vaccine supply lines may lead to...